Novel solutions driving discovery

The Aptamer Group is a young York (UK) based biotechnology company specialized in the development of nucleic acid aptamers, (‘synthetic anti-bodies’) for various applications within the Life Sciences.

Aptamers are oligonucleotides which are designed to specifically bind to a target of interest. The Aptamer Group has successfully isolated and optimized aptamers against targets ranging from small molecules, to peptides and proteins; even against complex systems such as viruses, whole cells and tissues. The selected aptamers are readily adapted to function in a variety of applications or environments. Their world-leading, parallel processing, aptamer discovery approach has been developed to ensure that their customers receive the best possible results and service.